Feed Articles

Cathie Wood returns to the limelight: investment moves to watch

Cathie Wood, co-founder and CEO of Ark Invest, is once again attracting attention with her innovative investment style focused on growth stocks. Its largest fund has seen a 17% rise in recent weeks after an earlier decline, putting it back in the spotlight for investors.

Thanks to Ark Invest's transparency, which publishes its trading activity on a daily basis, we have an overview of the companies it is currently buying.

Three purchases in particular are interesting: Advanced Micro Devices (AMD), DraftKings and Tempus AI. Let's take a closer look at these companies.

Advanced Micro Devices $AMD

What if the world of artificial intelligence (AI) started to develop in earnest, but one of the largest chipmakers, Advanced Micro Devices, was left on the sidelines? Although AMD is losing value in 2024, the company is looking to make its mark in AI. It is expected to unveil its plans at this week's "Advancing AI 2024" event, where it will unveil a new generation of accelerators, server processors and updates that bolster its ecosystem of AI solutions.

Despite suffering a 4% drop in revenue last year, AMD is now slowly returning to growth. A key segment is the data center division, which saw a 115% increase in sales. Although other parts of the business, such as the client and gaming segments, saw declines, AMD still holds the potential for significant growth. Analysts' outlooks for next year suggest revenue growth of 28%, and while AMD is not cheap, Cathie Wood clearly sees potential in the company.

DraftKings $DKNG

The sports season in full swing is a great opportunity not only for fans, but for betting platforms as well. DraftKings, a well-known online sportsbook, saw 8.4 million unique users in the last year, a 35% increase from the previous year. Although revenue growth slowed to 26% in the most recent quarter, DraftKings surprised with earnings and attracted analyst attention. Several firms have already upgraded the company's stock, indicating growing confidence on Wall Street.

With the NFL season kicking off and the NBA about to begin, DraftKings has all the ingredients to ride the wave of sports fever and capitalize on the enthusiasm of fans willing to bet on their favorite teams.

Tempus AI $TEM

Tempus AI is a newcomer to the stock market, but Cathie Wood isn't afraid to make risky bets. Tempus, which focuses on artificial intelligence applications in healthcare, debuted on the market with a share price of $37. Since then, it has seen dramatic growth and decline. The company is already generating real revenue, which grew 25% in the first quarter after going public. While profitability is not expected until 2027, Tempus is building a strong market position with its innovative approach to healthcare technology.

Like DraftKings, Tempus AI poses significant risk, but Wood sees great potential in the company. Her strategy of investing in pioneering and technologically advanced companies may pay off in the case of Tempus.

Disclaimer: There is plenty of inspiration to be found on Bulios, but stock selection and portfolio construction is up to you, so always conduct thorough self-analysis.

Source..

Stocks mentioned

A community member's personal view, not investment advice. Community Guidelines

Follow Bulios on Google News

Be among the first to discover new analyses, news and market moves.

Follow

Recommended articles

Read more

Expensive oil was supposed to sink them; these 3 cruise lines instead report records and expect further growth

Oil this year soared to $138 per barrel, and cruise ships, which burn hundreds of thousands of tons of it annually, were supposed to be the first to suffer. Instead, all three largest cruise operators raised their profit outlooks, yet for a dollar of profit the market pays almost twice as much for…

MC
Milan Charvat
· 6h
Read more
BLACK

Man with Parkinson's stood up and walked away after an injection. The drugmaker's stock still fell 20%

A man with Parkinson's who couldn't get up from a chair walked out through the door on his own after a year of treatment with his own cells. The company behind the treatment raised $140.6 million in its IPO, and three weeks later its stock is 20% cheaper, even though there hasn't been a single…

MC
Milan Charvat
· 10h
Read more
BLACK

Dividends Above 10%? No Problem for These Stocks

A yield of over 15% a year sounds almost unbelievable in the stock market, yet several established US-listed securities are offering just that today. Mortgage REITs and leveraged bond funds earn money from the difference between the yield on mortgages or bonds and the cost of short-term financing,…

KJ
Kryštof Jáně
· 13h

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy